CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- Open-market buys, last 90 days
- $158,000
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$158,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-20 | Irani Zackary S. Chief Executive Officer | Grant or award · Non Qualified Stock Option | +150,000 | 430,000 | ||
| 2018-12-20 | MOORE JANET Chief Financial Officer | Grant or award · Non Qualified Stock Option | +35,000 | 130,000 | ||
| 2018-12-20 | Sirgo Mark A Director | Grant or award · Non Qualified Stock Option | +35,000 | 95,000 | ||
| 2018-12-20 | BARBIERI ALLEN Director | Grant or award · Non Qualified Stock Option | +50,000 | 140,000 | ||
| 2018-12-20 | CANO FRANCIS Director | Grant or award · Non Qualified Stock Option | +35,000 | 125,000 | ||
| 2018-12-20 | Emerson Jane Director | Grant or award · Non Qualified Stock Option | +35,000 | 115,000 | ||
| 2018-12-20 | Irani Zackary S. Chief Executive Officer | Other acquisition | +400 | $2.45 | $980 | 920,129 |
| 2018-12-19 | Irani Zackary S. Chief Executive Officer | Other acquisition | +400 | $2.47 | $988 | 919,329 |
| 2018-12-19 | Irani Zackary S. Chief Executive Officer | Other acquisition | +400 | $2.45 | $980 | 919,729 |
| 2018-12-07 | Irani Zackary S. Chief Executive Officer | Other acquisition | +33,390 | $2.70 | $90K | 918,929 |
| 2018-10-26 | CANO FRANCIS Director | Option exercise | +25,000 | $0.75 | $19K | 166,736 |
| 2018-10-26 | CANO FRANCIS Director | Option exercise · Non Qualified Stock Option | −25,000 | 90,000 | ||
| 2018-10-19 | BARBIERI ALLEN Director | Option exercise | +25,000 | $0.75 | $19K | 160,289 |
| 2018-10-19 | BARBIERI ALLEN Director | Option exercise · Non Qualified Stock Option | −25,000 | 90,000 | ||
| 2018-10-05 | Emerson Jane Director | Option exercise | +25,000 | $0.75 | $19K | 71,000 |
| 2018-10-05 | Emerson Jane Director | Option exercise · Non Qualified Stock Option | −25,000 | 80,000 | ||
| 2018-05-23 | Sirgo Mark A Director | Other acquisition | +6,700 | $3.73 | $25K | 18,700 |
| 2018-05-23 | BARBIERI ALLEN Director | Other acquisition | +9,400 | $3.73 | $35K | 135,289 |
| 2018-05-23 | CANO FRANCIS Director | Other acquisition | +8,000 | $3.73 | $30K | 141,736 |
| 2018-05-23 | Irani Zackary S. Chief Executive Officer | Other acquisition | +25,000 | $3.73 | $93K | 885,539 |
Page 5 of 16 · 303 trades